{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:28:26Z","timestamp":1776374906193,"version":"3.51.2"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1757-2215-7-35","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T07:03:38Z","timestamp":1396508618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept"],"prefix":"10.1186","volume":"7","author":[{"given":"Jigal","family":"Haas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon","family":"Kedem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronit","family":"Machtinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shir","family":"Dar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Hourvitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil","family":"Yerushalmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raoul","family":"Orvieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"key":"243_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1071-5576(97)00113-5","volume":"5","author":"R Orvieto","year":"1998","unstructured":"Orvieto R, Ben-Rafael Z: Ovarian hyperstimulation syndrome: a new insight into an old enigma. J Soc Gynecol Invest 1998, 5: 110\u2013113. 10.1016\/S1071-5576(97)00113-5","journal-title":"J Soc Gynecol Invest"},{"key":"243_CR2","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/humrep\/13.12.3306","volume":"13","author":"R Orvieto","year":"1998","unstructured":"Orvieto R, Ben-Rafael Z: Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome. Hum Reprod 1998, 13: 3306\u20133309. 10.1093\/humrep\/13.12.3306","journal-title":"Hum Reprod"},{"key":"243_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fertnstert.2003.05.032","volume":"81","author":"S Kol","year":"2004","unstructured":"Kol S: Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 2004, 81: 1\u20135.","journal-title":"Fertil Steril"},{"key":"243_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/humrep\/deh613","volume":"20","author":"R Orvieto","year":"2005","unstructured":"Orvieto R: Can we eliminate severe ovarian hyperstimulation syndrome? Hum Reprod 2005, 20: 320\u2013322.","journal-title":"Hum Reprod"},{"key":"243_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/humupd\/dmi045","volume":"12","author":"G Griesinger","year":"2006","unstructured":"Griesinger G, Diedrich K, Devroey P, Kolibianakis EM: GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update 2006, 12: 159\u2013168.","journal-title":"Hum Reprod Update"},{"key":"243_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1472-6483(10)60615-3","volume":"13","author":"R Orvieto","year":"2006","unstructured":"Orvieto R, Rabinson J, Meltzer S, Zohav E, Anteby E, Homburg R: Substituting HCG with GnRH agonist to trigger final follicular maturation\u2013a retrospective comparison of three different ovarian stimulation protocols. Reprod Biomed Online 2006, 13: 198\u2013201. 10.1016\/S1472-6483(10)60615-3","journal-title":"Reprod Biomed Online"},{"key":"243_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.rbmo.2012.11.002","volume":"26","author":"S Kol","year":"2013","unstructured":"Kol S, Humaidan P: GnRH agonist triggering: recent developments. Reprod Biomed Online 2013, 26: 226\u2013230. 10.1016\/j.rbmo.2012.11.002","journal-title":"Reprod Biomed Online"},{"key":"243_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.fertnstert.2008.12.042","volume":"93","author":"P Humaidan","year":"2010","unstructured":"Humaidan P, Bredkjaer HE, Westergaard LG, Andersen CY: 1,500\u00a0IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin- releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril 2010, 93: 847\u2013854. 10.1016\/j.fertnstert.2008.12.042","journal-title":"Fertil Steril"},{"key":"243_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.rbmo.2011.11.001","volume":"24","author":"P Humaidan","year":"2012","unstructured":"Humaidan P, Papanikolaou EG, Kyrou D, Alsbjerg B, Polyzos NP, Devroey P, Fatemi HM: The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives. Reprod Biomed Online 2012, 24: 134\u2013141. 10.1016\/j.rbmo.2011.11.001","journal-title":"Reprod Biomed Online"},{"key":"243_CR10","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1093\/humrep\/det124","volume":"28","author":"A Seyhan","year":"2013","unstructured":"Seyhan A, Ata B, Polat M, Son WY, Yarali H, Dahan MH: Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500\u00a0IU hCG. Hum Reprod 2013, 28: 2522\u20132528. 10.1093\/humrep\/det124","journal-title":"Hum Reprod"},{"key":"243_CR11","first-page":"S188","volume":"90","author":"The Practice Committee of the American Society for Reproductive Medicine (ASRM)","year":"2008","unstructured":"The Practice Committee of the American Society for Reproductive Medicine (ASRM): Ovarian hyperstimulation syndrome. Fertil Steril 2008, 90: S188-S193.","journal-title":"Fertil Steril"},{"key":"243_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"L Engmann","year":"2008","unstructured":"Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C: The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomised controlled study. Fertil Steril 2008, 89: 84\u201391. 10.1016\/j.fertnstert.2007.02.002","journal-title":"Fertil Steril"},{"key":"243_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1757-2215-6-77","volume":"6","author":"R Orvieto","year":"2013","unstructured":"Orvieto R: Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma. J Ovarian Res 2013, 6: 77. 10.1186\/1757-2215-6-77","journal-title":"J Ovarian Res"},{"key":"243_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/oxfordjournals.humrep.a019329","volume":"11","author":"A Weissman","year":"1996","unstructured":"Weissman A, Loumaye E, Shoham Z: Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation. Hum Reprod 1996, 11: 943\u2013949. 10.1093\/oxfordjournals.humrep.a019329","journal-title":"Hum Reprod"},{"key":"243_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1210\/endo-117-3-1043","volume":"117","author":"JS Hutchison","year":"1985","unstructured":"Hutchison JS, Zeleznik AJ: The corpus luteum of the primate menstrual cycle is capable of recovering from a transient withdrawal of pituitary gonadotropin support. Endocrinology 1985, 117: 1043\u20131049. 10.1210\/endo-117-3-1043","journal-title":"Endocrinology"},{"key":"243_CR16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0015-0282(16)46095-4","volume":"37","author":"MG Hull","year":"1982","unstructured":"Hull MG, Savage PE, Bromham DR, Ismail AA, Morris AF: The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle (\u201covulation\u201d) derived form treated and untreated conception cycles. Fertil Steril 1982, 37: 355\u2013360.","journal-title":"Fertil Steril"},{"key":"243_CR17","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.fertnstert.2013.05.028","volume":"100","author":"HM Fatemi","year":"2013","unstructured":"Fatemi HM, Polyzos NP, van Vaerenbergh I, Bourgain C, Blockeel C, Alsbjerg B, Papanikolaou EG, Humaidan P: Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril 2013, 100: 742\u2013747. 10.1016\/j.fertnstert.2013.05.028","journal-title":"Fertil Steril"},{"key":"243_CR18","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.rbmo.2012.03.005","volume":"24","author":"R Orvieto","year":"2012","unstructured":"Orvieto R: Intensive luteal-phase support with oestradiol and progesterone after GnRH-agonist triggering: does it help? Reprod Biomed Online 2012, 24: 680\u2013681. 10.1016\/j.rbmo.2012.03.005","journal-title":"Reprod Biomed Online"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1757-2215-7-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:20:49Z","timestamp":1630552849000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/1757-2215-7-35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["243"],"URL":"https:\/\/doi.org\/10.1186\/1757-2215-7-35","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,3]]},"assertion":[{"value":"24 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"35"}}